| Code | CSB-RA011626MA1HU |
| Size | $49.9 |
| Order now | |
| Promotion | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| ELISA | 1:5000-1:50000 |
IL1RL1, commonly known as ST2, serves as the receptor for interleukin-33 and plays a pivotal role in immune regulation and inflammatory responses. This receptor has emerged as a particularly valuable biomarker in cardiovascular research, where soluble ST2 levels provide insights into cardiac stress, fibrosis, and heart failure prognosis. Understanding IL1RL1 signaling pathways continues to inform therapeutic strategies targeting inflammatory and cardiovascular conditions.
This recombinant monoclonal antibody, clone 8G2, offers researchers the reproducibility essential for longitudinal studies and multi-site collaborations. Because recombinant antibodies are produced from defined genetic sequences rather than traditional hybridoma methods, you can expect consistent performance across different lots, eliminating the variability that can compromise experimental comparisons over time. The antibody undergoes affinity chromatography purification, ensuring high purity for demanding applications.
Validation studies demonstrate robust binding activity in functional ELISA, with immobilized human IL1RL1 protein showing strong interaction with this antibody. The EC50 values ranging from approximately 7.7 to 66.4 ng/mL indicate sensitive detection suitable for quantitative applications. For ELISA workflows, dilutions between 1:5000 and 1:50000 provide flexibility to optimize signal-to-noise ratios based on your specific experimental conditions and sample concentrations.
The unconjugated format allows you to pair this antibody with your preferred detection systems, while the glycerol-based liquid formulation in PBS supports long-term stability when stored at recommended temperatures. For researchers investigating IL1RL1 biology in cardiovascular disease models, inflammatory pathways, or biomarker development programs, this antibody provides a sequence-defined tool with demonstrated binding performance against human IL1RL1.
There are currently no reviews for this product.